semaglutide mechanism of action diabetes GLP-1 Receptor Agonists as Treatments for Type 2 RYBELSUS® Mechanism of Action |

Nat Rev Gastroenterol Hepatol 18:599612 Lean MEJ, Leslie WS, Barnes AC et al (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

A medication originally developed for type 2 diabetes and obesitysemaglutidehas entered the spotlight for a completely unexpected reason

This creates a positive cycle where initial weight loss makes blood sugar easier to control, which in turn supports continued weight management

American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors

If the medication is stopped, the skin should be checked to confirm that the reaction improves, which can help support the idea that semaglutide was the cause

One major concern is, what will happen when people discontinue using a semaglutide and then regain weight